Serena Bertozzi

8PUBLICATIONS
13CO-AUTHORS
Obstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)Foetal development and medicineCancer geneticsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2025
Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61".

Alice Tassi, Ambrogio P Londero, Anjeza Xholli

|Jan 25, 2025
Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women.

Alice Tassi, Ambrogio P Londero, Anjeza Xholli

|Feb 25, 2023
Editorial: Precision Medicine in Obstetrics: Pregnancy Complication.

Serena Bertozzi, Bruna Corradetti, Arrigo Fruscalzo

|Feb 25, 2023
Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review.

Serena Bertozzi, Ambrogio P Londero, Anjeza Xholli

|Dec 22, 2022
Quantification of Women Who Could Benefit from Hormone Therapy after Endometrial Cancer Treatment: An Analysis of SEER Data.

Ambrogio P Londero, Anjeza Xholli, Serena Bertozzi

|Feb 25, 2022
Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery.

Ambrogio P Londero, Serena Bertozzi, Carla Cedolini

Pageof 2

Frequent Collaborators

6 joint publications

Ambrogio P Londero

4 joint publications

Anjeza Xholli

4 joint publications

Angelo Cagnacci

2 joint publications

Maria Orsaria